Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between
American Society of Clinical Oncology Educational Book · 2023-06 · (43)
DOI: 10.1200/edbk_390464 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023-06. Verfasst von Hyo Sook Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a very heterogeneous and aggressive breast cancer subtype with a high risk of mortality, even if diagnosed early. The mainstay of early-stage breast cancer includes systemic chemotherapy and surgery, with or without radiation therapy. More recently, immunotherapy is approved to treat TNBC, but managing immune-rated adverse events while balancing efficacy is a challenge. The purpose of this review is to highlight the current treatment recommendations for early-stage TNBC and the management of immunotherapy toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
- The University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA.
- Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL.
ORCID-Profile: Erica M Stringer-Reasor
Zitieren
APA
Han, H. S., Vikas, P., Costa, R. L. B., Jahan, N., Taye, A., & Stringer-Reasor, E. M. (2023). Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_390464
Vancouver
Han HS, Vikas P, Costa RLB, Jahan N, Taye A, Stringer-Reasor EM. Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_390464
BibTeX
@article{Han2023,
author = {Han, Hyo Sook and Vikas, Praveen and Costa, Ricardo L B and Jahan, Nusrat and Taye, Ammanuel and Stringer-Reasor, Erica M},
title = {Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between},
journal = {American Society of Clinical Oncology Educational Book},
year = {2023},
number = {43},
doi = {10.1200/edbk_390464}
}
EUVIMED